34D.F 101.75 (+1.24%)
IT0003492391• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. 34D.F

Diasorin (34D.F) Competitor Comparison

We are evaluating the key criteria listed to compare Diasorin (34D.F) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 55

Dividend yield

0 / 8

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Performance 5 years - 34D.F ranking 0 / 58

These are the competitors of Diasorin in the industry Diagnostics & Research ranked by performance 5 years
1. Lantheus Holdings LNTH
378.9
2. Natera NTRA
325.01
3. Medpace Holdings MEDP
268.49
4. RadNet RDNT
191.72
5. Meridian Bioscience VIVO
118.46
6. Twist Bioscience TWST
108.6
7. Waters WAT
69.65
8. Thermo Fisher Scientific TMO
65.89
9. Danaher DHR
65.71
10. Agilent Technologies A
63.79
11. DarioHealth DRIO
61.4
12. Laboratory Corp of America Holdings LH
56.31
13. Mettler-Toledo MTD
55.33
14. PerkinElmer PKI
48.44
15. IDEXX Laboratories IDXX
44.14
16. DexCom DXCM
42.9
17. Quest Diagnostics DGX
41.4
18. Qiagen QGEN
33.33
19. IQVIA Holdings IQV
22.24
20. Fulgent Genetics FLGT
19
21. Ortho Clinical Diagnostics Holdings OCDX
13.74
22. Icon ICLR
12.37
23. Heska HSKA
12.14
24. Co-Diagnostics CODX
6.45
25. Charles River Laboratories CRL
2.14
26. CareDx CDNA
-9.61
27. Syneos Health SYNH
-16.98
28. Inotiv NOTV
-22.92
29. Olink Holding OLK
-26.82
30. Anixa Biosciences ANIX
-32.11
31. Bioventus BVS
-33.51
32. Exact Sciences EXAS
-42.52
33. Sotera Health SHC
-51.93
34. Guardant Health GH
-56.27
35. NeoGenomics NEO
-56.78
36. Illumina ILMN
-57.13
37. Sera Prognostics SERA
-57.23
38. Myriad Genetics MYGN
-57.71
39. Personalis PSNL
-61.22
40. Enzo Biochem ENZ
-65.26
41. Neogen NEOG
-67.09
42. Pacific Biosciences of California PACB
-67.4
43. MaxCyte MXCT
-70.92
44. National Research NRC
-74.13
45. Trinity Biotech TRIB
-81.02
46. Psychemedics PMD
-81.41
47. Exagen XGN
-83.67
48. MDxHealth MDXH
-83.87
49. Precipio PRPO
-84.57
50. Global Cord Blood CO
-86.47
51. Interpace Biosciences IDXG
-86.51
52. bioAffinity Technologies BIAF
-88.45
53. Biodesix BDSX
-91.54
54. Neuronetics STIM
-92.42
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-95.27
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.